Type two innate lymphoid cells: the Janus cells in health and disease.
Hadi MaaziOmid AkbariPublished in: Immunological reviews (2018)
Innate lymphoid cells are functionally diverse subsets of immune cells including the conventional natural killer cells, lymphoid tissue inducers, type 1, 2, and 3 with significant roles in immunity and pathogenesis of inflammatory diseases. Type 2 innate lymphoid cells (ILC2s) resemble type 2 helper (Th2) cells in cytokine production and contribute to anti-helminth immunity, maintaining mucosal tissue integrity, and adipose tissue browning. ILC2s play important roles in the pathogenesis of allergic diseases and asthma. Studying the pathways of activation and regulation of ILC2s are currently a priority for giving a better understanding of pathogenesis of diseases with immunological roots. Recently, our laboratory and others have shown several pathways of regulation of ILC2s by co-stimulatory molecules such as ICOS, regulatory T cells and by compounds such as nicotine. In this review, we summarize the current understanding of the mechanisms of activation and regulation of ILC2s and the role of these cells in health and disease.
Keyphrases
- induced apoptosis
- cell cycle arrest
- adipose tissue
- healthcare
- endoplasmic reticulum stress
- type diabetes
- public health
- signaling pathway
- oxidative stress
- mental health
- chronic obstructive pulmonary disease
- cell death
- risk assessment
- cystic fibrosis
- cell proliferation
- air pollution
- natural killer cells
- climate change
- nk cells
- atopic dermatitis
- peripheral blood